Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration and tracheal tubes (A61M16)

Control of patient interface means fixation // 2642727
FIELD: medicine.SUBSTANCE: first version of the system contains a patient interface means to supply a gas stream to the patient. The interface means comprises a headband for securing to the patient and a mechanism for fixing force adjustment. The system includes a device for monitoring the degree of blood flow through the patient's blood vessel. The device contains a sensor and a control unit. The sensor detects the data on the blood flow through the blood vessel and is connected to the control unit to transfer the data to the control unit. The control unit is able to receive data from the sensor and to estimate the degree of blood flow based on the data mentioned. The control unit is able to provide a signal based on the blood flow in the blood vessel. The system comprises an adjusting mechanism controlling the force of patient interface means fixation by means of the headband, based on the signal provided by the detection device. In a second version of the system, the evaluation unit controls the audio signal generator to generate a warning signal if the degree of blood flow in the blood vessel or the degree of blood vessel occlusion passes a predetermined threshold. A warning signal indicates that the fixation force of the interface means is too strong. The force should be adapted by the adjusting mechanism. The method for prevention of red marks formation comprises the steps of interface means fixation to the patient by means of fixation force. The degree of blood flow through the patient's blood vessel is then assessed. Further, the fixation force is adjusted so that blood flow is present and that the blood flow exceeds a predetermined threshold.EFFECT: creation of a system and method that ensures reduction of red marks, and increased comfort of wearing of the patient interface means.15 cl, 5 dwg
ethod for anesthesia in surgical treatment of varicosis // 2641860
FIELD: medicine.SUBSTANCE: conductor anesthesia and tumescent anesthesia are performed. With this, an echocontrolled conductive anesthesia of the femoral and / or sciatic nerves is performed. At femoral nerve anesthesia a puncture is performed in the place of nerve visualization, 0.5-1 cm above the inguinal fold, and for the sciatic nerve - at the point of tibial and peroneal nerves division. The dose of lidocaine in the blockade is 40, 200, 400 mg per blockade, depending on the individual characteristics of the patient and the volume of the operation. After echo-controlled conductive anesthesia, tumescent anesthesia is performed in the fascial case of the large or small saphenous vein in the miniplebectomy zone using an automatic pump. If it is necessary to intervene on the trophic ulcer, an application of cream with local anesthetics is performed 2 hours prior to the surgery on its surface.EFFECT: method allows to increase the effectiveness of anesthesia, avoiding the potential risks of regional anesthesia and can be performed on an outpatient basis.2 cl, 3 ex

Patient interface devices // 2641836
FIELD: medicine.SUBSTANCE: cushion is designed for the patient interface device to supply the respiratory gas to the patient's airway, which contains a mask to feed gas into the nose and/or into the mouth limiting the volume of the mask. The cushion has a flexible pressure valve that extends inside the mask from the outer edge of the mask volume and is arranged to contact the patient's skin to provide at least a partial seal between the mask volume and the environment. The pressure valve comprises a cavity region to be positioned adjacent to the patient's skin and between the mask volume and the patient's skin. The pressure valve also comprises a gas-impermeable layer located above the said region. The said region of the cavity is subjected to a reduced pressure compared to the mask volume. The interface device and the patient interface unit for respiratory gas supply to the patient's airway are disclosed.EFFECT: improve contact of the mask with the patient's skin.9 cl, 7 dwg

Patient interface device // 2641371
FIELD: medicine.SUBSTANCE: patientinterface device comprises a sealing unit to supply a flow of respiratory gas to the patient, a fixing assembly to secure the sealing assembly to the patient's face, and comprising a force limiter to limit the force between the patient interface device and the patient's face to a maximum predetermined force when the patient interface device is attached to the patient. The force limiter comprises the first and second connecting members constituting a self-releasable interference fit to transfer force from the first to the second connecting member and to release the interference fit between the two connecting members when the force exceeds the maximum specified force. A headband assembly is disclosed to secure the patient interface on the patient's face.EFFECT: reduced patient's discomfort when wearing a mask for a long time, which can occur due to an inadequate effort when putting on a mask.12 cl, 3 dwg
ethod for treatment of sustainable paroxismal states and generalized myoclonia in patients with consequences of heavy damage to brain // 2641163
FIELD: medicine.SUBSTANCE: patients subjected to medical anaesthesia. The trachea is intubated and the patient is transferred to artificial lung ventilation. At that, after trachea intubation and transfer to artificial lung ventilation, medical anaesthesia is performed, including inhalation anaesthesia with Sevoflurane at a dose of 2.0-3.0 vol % MAC 0.8-0.9 for 24-48 hours and additional intravenous infusion of Ketamine in a dose of 1-2 mg/kg-h for 2 hours, starting from the 2nd hour of medical anaesthesia. Artificial lung ventilation is carried out on a semi-closed contour in the "Pressure control" or "Pressure support" mode under the control of capnometry and arterial blood gases analysis.EFFECT: method allows to increase the effectiveness of treatment of paroxysmal and persistent generalized myoclonia in patients with consequences of heavy brain damage due to the lasting effect of seized paroxysms and hyperkinesia after termination of medical anaesthesia with application of Sevoflurane and Ketamine.1 ex

Respiratory mask with nose support element-expander // 2640984
FIELD: items for personal use.SUBSTANCE: basis of the respiratory mask is provided, which has the nose area, including the seal and the support element-expander. In one embodiment, the mask basis has the nose area, including the support element-expander, extending in the direction away from the seal and having the configuration in which it is in contact with the user's nose outside the seal.EFFECT: usability increase.17 cl, 6 dwg

Tray patch with side stabilisers // 2640443
FIELD: medicine.SUBSTANCE: tray patch for the patient interface device comprises a central portion of the sealing body defining an inner chamber. The upper wall of the central portion includes a central sealing surface adapted to engage the septum and the lower portion of each nostril of the patient, the first stabilising surface and the second stabilising surface. Each of the first and second stabilising surfaces extends upward and outward relative to the central sealing surface and the upper edge of the front wall in the direction from the bottom wall and is configured to be wrapped around the outside of the corresponding one of the patient's nostrils and engage by its parts with the outside of the corresponding one of the patient's nostrils when the patient wears the interface device. The first stabilising surface comprises the first edge portion of the front side. The second stabilising surface comprises the second edge portion of the front side, the upper edge of the front wall, the first edge portion of the front side and the second edge portion of the front side jointly forming a front opening of the central portion of the sealing body. The patient interface device and the system for respiratory gas flow delivery to the patient are disclosed.EFFECT: ensured reliable sealing when using the respiratory interface.17 cl, 17 dwg

Compensation for artificial respiration // 2639853
FIELD: medicine.SUBSTANCE: method for gas delivery during ventilation uses an artificial respiration system comprising a patient-tube system connected to the outlet of the gas delivery system to transfer gas to the patient during inhalations with addition of gas; a flow sensor connected to the said outlet for gas flow measurement, a patient-tube pressure sensor coupled to the said patient-tube system to measure the gas pressure therein and provide pressure signals in the patient-tube system representing the said pressure. The processor is connected to these sensors and is able to receive pressure and flow signals from them. According to the method, flow information from the said flow sensor is obtained in one sample, pressure information from the said patient-tube system pressure sensor is obtained in one sample and calculated for the said one sample based on the flow information from the said flow sensor and pressure information from the said patient-tube pressure sensor, the amount of gas necessary to compensate for the gas lost when creating excess pressure in the patient-tube system and the gas lost due to leakage in the patient-tube system. The compensated amount of gas based on the specified calculation is delivered. An artificial respiration system and a machine-readable medium storing the program for method implementation are disclosed.EFFECT: provision of sufficient pressure to deliver gas into the patient's lungs.11 cl, 13 dwg

Patient interface with gasket for red traces prevention // 2639034
FIELD: medicine.SUBSTANCE: patient interface is designed to supply gas to the patient and comprises a spacer element and a dielectric elastomeric actuator with a sensitive material for changing the pressure from the gasket element acting on the patient and/or the area on the patient, where pressure is applied by the spacer element in response to physical value acting on the sensitive material. The spacer element comprises a sensitive material or is attached to a sensitive material. The sensitive material is an electroactive polymeric material, a thermosensitive polymeric material, or a photosensitive polymeric material. A system for gas supply to the patient, a gasket element for use in the patient interface, and a method for prevention of formation of red traces caused by the patient interface are disclosed.EFFECT: increased comfort with long wearing of the interface.13 cl, 10 dwg

Patient interface and method of its manufacture // 2639019
FIELD: medicine.SUBSTANCE: interface system and structure of positioning and stabilization of a sealing component on patient's head for the delivery of air or breathing gas mixture under the positive pressure to the entrance of patient's respiratory tract contain compressing structure with back straps, between which there is a segregation area. The back straps are made converging, and the side sections of the structure contain stiffeners.EFFECT: adjusting the tension force by varying the distance between back straps.13 cl, 222 dwg

Surninov's respiratory training device // 2638277
FIELD: medicine.SUBSTANCE: training device contains a primary capacity and an additional capacity connected to each other. The primary capacity comprises a face mask, inlet opening with an inlet valve, a source of high-frequency air vibrations as an electric sound transmitter, a source of low-frequency air vibrations as a resonator tube with valves mounted on the tube ends, a twin-tube fluid manovacuummeter, devices for control and notification on the content of dangerous oxygen and carbon dioxide concentrations, the additional capacity comprises a bypass opening, a source of negative aerohydroions as a high voltage electrode with a sab and a grounding electrode. At that, the valves of the low-frequency air vibrations source are installed at one end of the resonator tube and the high-voltage electrode with the swab of the negative aerohydroions source is directed towards the inlet opening.EFFECT: invention allows to increase the efficiency of mastering and maintaining of economical breathing.3 cl, 1 dwg

Portable air cleaner // 2637828
FIELD: ventilation.SUBSTANCE: portable air cleaner contains the main unit, the mask and the flexible tube for connecting the main unit to the mask. The main unit comprises the pressure increase and filtration chamber, containing the pump and the filter unit. The filter unit is located at the inlet of the pressure increase and filtration chamber. The main air-storage chamber contains the negative ion generator, located in it. The auxiliary air-storage chamber contains the pressure sensor, located in it. The pressure increases and filtration chamber is connected to the main air-storage chamber by means of the ejector opening. The main air-storage chamber is connected to the auxiliary air-storage chamber through the valve. The filter unit contains the high-purity filter, the mesh size of which is less than 2.5 micrometres. The pressure increases and filtering chamber contains the ejector tube, one end is connected to the pump and the other is connected to the ejector opening.EFFECT: elimination of the device contamination problem, connected with the particles smaller than 2,5 micrometres in order to reduce the human inhalation risk of harmful substances from the environment.8 cl, 1 dwg

Hose device for fluid // 2636863
FIELD: medicine.SUBSTANCE: fluid hose devices includes a fluid hose through which fluid can be transported, and has a number of bump-preventing protrusions spaced from each other by a certain interval and formed in the longitudinal direction of the fluid hose, the protrusions are annular around the outer surface of the fluid hose. A group of a certain number of interconnecting mesh jumpers is made in each case between two adjacent bump-preventing protrusions. The mesh jumpers connect adjacent protrusions. The groups are arranged in the form of an alternating chevron interlacing in the longitudinal direction of the fluid hose.EFFECT: reduced bending of the hose while maintaining its flexibility.14 cl, 8 dwg

Pediatric face mask // 2635467
FIELD: medicine.SUBSTANCE: group of inventions refers to a mask assembly for use in a system supplying a flow of therapeutic gas to the respiratory tract of a pediatric patient (as defined in claim 1); a system for therapeutic gas supply to the respiratory tract of a pediatric patient (as defined in claim 8); a kit for use in a system supplying a flow of therapeutic gas to the respiratory tract (as defined in claim 13). The mask assembly (10) comprises a mask body (12) having an opening (13) adapted to receive the supplied therapeutic gas. The mask assembly (10) has a flexible peripheral sealing structure (20) having the first side (504) connected to the mask body. The sealing structure (20) has the opposite second side (508) including an opening (510) adapted to receive the face of the pediatric patient. The second side interacts with the seal with the face perimeter of the pediatric patient. The hole is defined by its height (H) and width (W). The ratio of hole height to width is in the range of about 0.83 to about 0.87. The system comprises a pressure/flow generation system (42). The system has a tube element (40) having the first end connected to a pressure/flow generation system and the opposite second end and a mask assembly (10). The kit comprises a mask assembly (10) and a plurality of headband assemblies. Each headband assembly is configured to selectively connect to the mask assembly. The headband assembly contains a colour for referring to a male patient and a colour for referring to a female patient.EFFECT: maximized comfort while minimizing leakage during the supply of excessive pressure to the respiratory tract of a pediatric patient.15 cl, 9 dwg

Respiratory therapy mode unlocking // 2635182
FIELD: medicine.SUBSTANCE: system and method contain: one or more processors configured to execute computer program modules. The computer program modules comprise: a data acquisition module configured to receive usage information relating to the respiratory therapy device. Information on usage taken from the respiratory therapy device represents the therapeutic use of the respiratory therapy device. Information on usage taken from the respiratory therapy device further represents an index relating to the effectiveness of therapy provided by the respiratory therapy device. Information on usage taken from the respiratory therapy device further represents the index of respiratory failure. An analysis module, configured to determine information related to the effectiveness of therapy provided based on the accepted usage information. The operator interface module, configured to receive the first selection of unlocking based on the information related to the effectiveness of therapy, while the respiratory therapy device operates in the first mode of therapy. The first selection of unlocking indicates that the second mode of therapy for the respiratory therapy device should be unlocked. The second mode of therapy is not available for use in the respiratory therapy device until the first selection of unlocking is received. The device configuration module is made, such that in response to reception of the first unlocking selection by the operator interface module, the device configuration module activates the second mode of therapy for the respiratory therapy device. The device configuration module is further configured to deactivate the second mode of therapy after the predetermined trial period is over. The unlocked second mode of therapy includes one or both of the multi-level pressure and/or automatic titration modes. The device configuration module is further configured such that, in response to reception of the first unlocking selection, the device configuration module instructs the respiratory therapy device to activate the selectable acceptance field. Selection of the selectable acceptance field by the user indicates the acceptance of a second mode of therapy, and the activation of the second mode of therapy for the respiratory therapy device additionally occurs in response to user selection of the selectable acceptance field.EFFECT: system improvement.7 cl, 6 dwg

Portable manual system and pressure support method // 2635005
FIELD: medicine.SUBSTANCE: system is configured to supply a stream of respiratory gas under pressure to the respiratory tract of the subject. The said pressure support system comprises: a pressure generator configured to generate a respiratory gas stream under pressure; a subject interface adapted to transmit a respiratory gas stream under pressure to the respiratory tract of the subject; one or more sensors configured to generate output signals carrying information associated with one or more gas parameters of the respiratory gas stream under pressure; one or more processors configured to control the pressure generator operation to generate a pressurized gas stream based on the output signals of one or more sensors in accordance with a positive pressure maintenance therapy mode; a portable power supply, able to supply the pressure generator, one or more sensors, and one or more processors; a housing configured to receive the pressure generator, the subject interface, one or more sensors, one or more processors, and the power source; and a handle attached to the body and/or formed by the body, configured to be grasped by the patient to hold the body in some position relative to the subject's respiratory tract as the respiratory gas stream under pressure is supplied to the respiratory tract of the subject.EFFECT: improvement of the device.15 cl 3 dwg
ethod of diagnostics of microcirculatory bloodstream state in cardiac-surgery patients during artificial circulation // 2634634
FIELD: medicine.SUBSTANCE: for the diagnostics of the microcirculatory bloodstream state during the artificial circulation (IC) in cardio-surgery patients throughout the period of IR with a respiratory volume of 4 ml/kg, respiratory rate 5 in 1 min, PEEP 5 cm wat. col., FiO2 0.3-0.4 the partial pressure of carbon dioxide (CO2) at the end of exhalation (PetCO2) is evaluated according to capnography monitoring data. If PetCO2 decreases below 8 mm wat. col. or more than 2 times from the values at the initiation of the IR, centralization of the blood circulation is diagnosed.EFFECT: allows to diagnose disorders of microcirculation when conducting artificial circulation, which makes it possible to conduct therapy aimed at decentralization of blood circulation in time, reducing the number of complications in the postoperative period in patients and improving the results of cardiosurgical interventions.1 ex
ethod for subdural analgesia as method for analgesia in first delivery period // 2633933
FIELD: medicine.SUBSTANCE: in the first delivery period, the puncture site is anesthetized with a solution of bupivacaine 0.5%. The subdural space is then punctured with a spinal needle at the level L3-4, L4-5 by median access, using an isobaric solution of bupivacaine 0.5% in doses of 0.8-1.2 ml as a local anesthetic. At that, the woman after the puncture remains lying on her side for 2-3 minutes, then turns to the opposite side for 2-3 minutes.EFFECT: decreased drug effect on the maternal and fetal organism, ensured rapid onset of qualitative and prolonged analgesia of the first delivery period.1 ex

ethod and system for mdi electronic model (dosing inhalant device) // 2633269
FIELD: medicine.SUBSTANCE: method for aerosol cloud formation is performed by means of a device containing a metered-dose inhaler under pressure (MDI) containing the drug solution used with hydrofluoroalkane (HFA) propellants. The MDI inhaler volume is connected to an electronic valve. The valve is designed to receive control signals from the microprocessor. During method implementation, a set of drug parameters is stored in the memory device, this set comprises a quantitative indicator indicating the total amount of the aerosol medicament to be dispensed during the drug administration session; opening of the electronic valve is controlled, providing dosing of the total amount of the aerosolized drug during inhalation time by successive low-volume pulses. The time interval between pulses is between 20 and 50 ms. The volume of drug delivered during one pulse is less than 5 μl. Duration of each pulse is determined so that the fraction of respirable particles (FPF) of the aerosol drug is maximized and the amount of FPF fraction of the aerosol delivered during one pulse is calculated to minimize the inhalation time. An aerosol dispenser and a computer-readable medium for recording an aerosol cloud formation control program are disclosed.EFFECT: ensured delivery of the optimal drug dose.11 cl, 11 dwg, 8 tbl

Laryngeal mask with tube installed over glottis // 2632522
FIELD: medicine.SUBSTANCE: laryngeal mask contains a tube placed above the glottis to insert the laryngeal mask head through the larynx. The tube, installed above the glottis, has three lumens, namely a respiratory lumen for respiratory air and instrumentation supply, an esophageal lumen for esophageal access and a proximally closed guide lumen passing medially between them. The tube installed above the glottis and the laryngeal mask head are made in one piece by injection moulding. Between the lateral lumen and the medial guide lumen, on the part of the tube length placed above the glottis, starting from the distal end, a slot passes connecting the two lumens. A mould for injection moulding for the laryngeal mask manufacture, where three parallel rods are provided to form a tube positioned above the glottis. The rod to forming the guide lumen and one of the adjacent rods, starting from the proximal end, are connected to each other in the distal direction by means of a stabilizing bridge.EFFECT: increased wear resistance of rods, eliminated formation of films and membranes, reduced number of operations during production and control.16 cl, 9 dwg

System and method for determination of target temperature for means of interaction with subject based on basic temperature // 2631185
FIELD: medicine.SUBSTANCE: pressure support system comprises a heater of the means for interaction with the subject, configured to control heating of the inspiratory gas stream under pressure to a target temperature that is changed compared to the reference temperature. The target change in the baseline temperature of the inhaled gas ensures that the gas supplied to the subject has a comfortable level of temperature and/or humidity that does not cause dryness in the airways or leads to water condensation in the interaction medium. For one version, the pressure support system comprises one or more pressure generators, a means for interaction with the subject, a heater for interaction with a subject, one or more temperature sensors of the interaction means, one or more base temperature sensors, one or more general purpose sensors, a humidifier, a user interface, a processor, an electronic memory, and/or other components.EFFECT: providing treatment for a subject with pressure support.15 cl, 2 dwg
ethod for anesthetic maintenance during radical surgery for cancer patients // 2627289
FIELD: medicine.SUBSTANCE: after patient admission to the operating room dexmedetomidine administration starts at a dose of 0.6-0.8 mcg/kg/h. Then epidural space catheterization is perform lying on the side. Analgesic mixture administration starts at a rate of 5 ml/hour and continued throughout the operation. During denitrogenation, intravenous dexmedetomidine sedation is performed at an dose of 0.6-0.8 mcg/kg/hr, after repeated denitrogenation and transition to closed circuit, oxygen supply is stopped. The breathing bag is completely emptied, then Xe is fed rapidly, once filling the breathing bag, ventilation by pure Xe flow of 150-300 ml per minute is begun under the control of FiO2 to reduce the oxygen concentration in the breathing circuit to 40% and Xe concentration to 60%, and then oxygen is supplied at a dose of 4 ml/kg, maintaining the balance in the ratio of Xe:O2 60:40. Xe flow is reduced to 0-100 ml/min intravenous administering of dexmedetomidine is continued throughout the operation at a dose of 0.3-0.6 mcg/kg/hr. Prior to surgical wound suturing Xe supply is stopped. After surgery, anesthesia machine is converted to a semi-open circuit, oxygen flow is increased to 5 l/min, sodium sugammadex is introduced at the rate of used bromide rocuronium. The patient extubated, in the early postoperative period analgesic mixture administration is continued at a rate of 5 ml/hr and intravenous dexmedetomidine administration is continued at a dose of 0.3-0.6 mcg/kg/h under the control of sedation level and hemodynamics.EFFECT: method allows to obtain an efficient multimodal anesthetic protection, reduce xenon and narcotic analgesics consumption during extended and highly-traumatic cancer surgery.2 ex

Laryngeal videomask with rigid retracting tab and tool for ventilation and intubation // 2626902
FIELD: medicine.SUBSTANCE: device comprises a rigid tube, substantially J-shaped, having a longitudinal hole along its entire length, a flexible tube also J-shaped, intended to be placed into the longitudinal opening of the rigid tube and detachable. The flexible tube has an inflatable or gel laryngeal ring at its distal end. The rigid tube has a rigid projection in the form of tab at its distal end. The Flexible tube has a flexible sheath at its distal end intended to receive rigid protrusion in the form of the rigid tube tab. The rigid protrusion is located in the interior of the flexible sheath when the rigid tube and flexible tube are connected.EFFECT: increased stability of mask position and airway passage blocking exception.21 cl, 16 dwg
ethod for bronchial asthma treatment // 2626768
FIELD: medicine.SUBSTANCE: CPAP therapy is conducted using a nasal or mouth-nose mask. In case of single-level CPAP therapy using the RESMART CPAP apparatus without automated upper inspiratory limit, the therapeutic exhalation pressure (EPAP) comfortable for the patient is selected. When the RESMART CPAP Auto apparatus with automated upper inspiratory limit is used, the exhalation pressure is set to 5-8 centimeters H2O, the maximum pressure is 20 centimeters H2O. In case of a two-level CPAP therapy, if the RESMART BPAP 25 Auto apparatus has the automated upper inspiratory limit, the exhalation pressure is set to 5-10 centimeters H2O, pressure support is 12-17 centimeters H2O, the maximum pressure is 25 centimeters H2O. The humidifier operating temperature is 37°C. CPAP therapy is performed outside bronchial asthma exacerbation in the morning and evening for 30-60 minutes. At an exacerbation - prior to bronchospasm arresting from 5 to 16 times a day.EFFECT: method allows to effectively treat bronchial asthma by reducing pressure accumulated inside the alveolus with the use of optimal regimens of CPAP therapy.2 cl, 1 tbl, 4 ex

ethod for non-invasive artificial lung ventilation for newborns and device for its implementation // 2626305
FIELD: medicine.SUBSTANCE: breathing system containing a patient interface and a CPAP pneumoelement, in accordance with which, a damp air-oxygen breathing mixture is made up and supplied to the breathing system. The desired value of the breathing mixture constant overpressure at the respiratory circuit output is specified, the actual pressure of the breathing mixtures on the output of this circuit is measured, the measured and the specified pressure values are compared, the value of misalignment is determined, then breathing mixture flow control signals are formed continuously and output to control the flow until the said misalignment is eliminated. At that, the control signals frequency is significantly higher than the frequency of patient's respiratory cycles. At that, it is supplemented with the following new operations: for a specific interacting breathing system, this system is automatically tested and during the testing process, values of the two correction factors are calculated and stored: the first factor characterizing the time constant of the CPAP pneumoelement and the second factor characterizing the air resistance of the breathing system. Then, taking into account the calculated values of the correction factors, the required value of the constant excess pressure at the breathing system output is clarified and stored, proceeding from the requirement that during the entire respiratory cycle, including during inspiration, it should not fall below atmospheric pressure, then the flow rate of the breathing mixture is controlled, such that the value of the excess pressure at breathing system output is maintained substantially constant and equal in magnitude to the refined predetermined value during the entire respiratory cycle. The device for method implementation includes a breathing mixture flow control module comprising the first controllable valve, a control unit, an information input and display module, a pressure pneumatic duct with a breathing mixture humidifier of the, and the first and second pressure sensors, the output of each of which is connected to a corresponding input of the control unit. Moreover, the breathing mixture flow control module is equipped with a pneumatic channel for air supply, a pneumatic channel for oxygen supply and a pneumatic output connected to the delivery pneumatic channel input, the output of which is intended for connection to the breathing system. At that, the first pressure sensor is provided with a pneumatic port for connection to the breathing system output, and the control unit output is connected to the control input of the first controllable valve, and the information input and display unit and the control unit are interconnected by a bidirectional communication line. In addition, a pressure stabilization module including a stabilization circuit and a preset pressure memory cell connected to this circuit and a correction factor unit comprising the first and second calculators connected to the stabilization circuit by information lines are added to the control unit. The pneumatic port of the second pressure sensor is connected to the discharge pneumatic channel output, and the electrical output of this sensor is connected to the corresponding input of the control unit.EFFECT: method and device allow to use any kind of breathing systems with various CPAP pneumoelements and patient interface devices for the IVL procedure.4 cl, 1 dwg

Automated adjustment of synchronising with patient for non-invasive lungs ventilation // 2626113
FIELD: medicine.SUBSTANCE: respiratory therapy system contains a pressure generator, sensors for generation of output signals transmitting information related to one or more gas parameters for a pressurized gas stream; and processors for computer program modules execution. Computer program modules contain a trigger module; a muscle strain module determine the subject's muscular tension based on the output signals; an error detection module, a sensitivity module for trigger parameters adjustment, and a control module. The control module controls the pressure generator to adjust the gas parameters for the pressurized breathing gas flow as a function of time in accordance with the respiratory therapy regimen. The respiratory therapy regimen determines the adjustment of gas parameters based on the detected trigger events.EFFECT: provision of a respiratory therapy regimen adjusted in accordance with the detected trigger events.5 cl, 4 dwg
ethod for production and delivery of hypoxic and hypercapnic-hyperoxic mixtures for medical procedures, and device for its implementation // 2625594
FIELD: medicine.SUBSTANCE: hypoxic and hyperoxic mixtures for medical procedures are produced by air compression, its subsequent filtering, moisture separation and division by passing through a separator, made of a hollow fiber polymer membrane. Next, for therapeutic procedures, hypoxic and hypercapnic hyperoxic mixtures are alternately supplied to the consumer's respiratory mask, providing intake of the mixture coming from the separator and release of the patient's exhaled air. The atmospheric air is compressed after mixing with the exhaled air coming from the respiratory mask. The device for method implementation comprises serially installed compressor, air preparation system made as a heat exchanger with a condensate collector, gas separating membrane module configured as a set of groups of single membrane elements placed in a casing provided with air inlet fittings, hypercapnic- and hyperoxic mixtures outlet fittings; humidifier, receivers, patient connection unit comprising a respiratory mask with inlet and outlet valves and patient condition monitoring means including an oxygen analyzer and a pulse oximeter; hypoxic and hypercapnic-hyperoxic mixture supply system, provided with automatically switching valves providing hypoxic and hypercapnic hyperoxic mixture supply to the patient and exhaled air removal, as well as control system, is characterized by the outlet valve of the respiratory mask connected by a hose at theexhalation air mask outlet to the fittings for atmospheric air supply to the compressor which is equipped with a device for regulation of the incoming gas mixture flow. The air preparation system is equipped with a quick-detachable filter to absorb harmful impurities and microorganisms contained in the exhaled air, and the hollow fibers of the membrane module are made of a polymer highly selective to oxygen and carbon dioxide gas - polyimide.EFFECT: method allows to simultaneously obtain hypoxic and hyperoxic mixtures with increased carbon dioxide concentration in the latter without switching the flow direction of the incoming atmospheric air flow, reduce the loss of hypoxic and hyperoxic mixtures, as well as carbon dioxide during medical procedures.5 cl, 4 dwg

Improved retaining device // 2622363
FIELD: medicine.SUBSTANCE: invention relates to medical equipment. The airway device comprises an airway tube with the first end and the second end, the first end of the airway tube is surrounded by a laryngeal cuff and the laryngeal cuff includes a rear dorsal portion, a front face portion and a tip portion, the front face portion of the laryngeal cuff has a shape suitable to form an anatomical fit over the laryngeal inlet of the patient - a person or an animal, and to form a seal with the laryngeal inlet of the patient, wherein the tip portion includes an annular sealing bead. The annular sealing bead is adapted to be secured by a wedge in the top part of the patient's (a person or an animal) esophagus. The annular sealing bead is provided for improved sealing of the laryngeal cuff tipin the top part of the patient's (a person or an animal) esophagus. The annular sealing bead is preferably made of soft plastic polymer or other material.EFFECT: annular sealing bead allows better sealing with greater variability of the upper esophageal area anatomical characteristics.12 cl, 48 dwg
ethod for lung ventilation during thoracic surgery in lung cancer patients with concomitant chronic obstructive pulmonary disease // 2621381
FIELD: medicine.SUBSTANCE: high-frequency mechanical ventilation is provided. At that, high-frequency ventilation is performed using oxygen in catheter ventilation mode at a frequency of 90-95 cycles per 1 min at gas flow rate of 5-7 l per 1 min. Additionally, via a micro pump nebulizer, embedded into the breathing system, Spiriva bronchial spasmolytic is injected into the independent lung during the main phase of surgical intervention at a dose of 18 g, dissolved in 4 ml of physiological solution, in two steps by 2 ml of the prepared solution for 15 min with 60 min intervals between introductions.EFFECT: method allows to increase the effectiveness of ventilation support in patients with lung cancer and COPD due to bronchospasm reduction and improvement of capillary-alveolar gas exchange.1 ex, 2 tbl, 1 dwg

Device for respiratory diseases treatment and lung function gain // 2619375
FIELD: medicine.SUBSTANCE: device for lung function improvement comprises the first gas flow path for inhalation, a housing and a space for fluid formed in the housing. The second gas path communicates with the housing and is designed to transfer the exhaled gas to the space for fluid. Vapour space is configured to receive vapour formed in the space for fluid, and the first gas path communicates with the vapour space. The mouthpiece for airflow direction from the first gas path to the user during inhalation, and for reception of gas exhaled by the user. Means to transfer the exhaled gas flow from the mouthpiece to the housing along the second gas path provides resistance to the exhaled gas flow passing through the second gas path, and increases the pressure in the space for fluid and vapour. The relief valve prevents an excessive rise in pressure inside the device during exhalation. The air replacement valve supplies air during inhalation of to replace air in the vapour space. Means for gas flow transfer during inhalation from the vapour space to the mouthpiece along the first gas path comprises the first valve to prevent gas from entering through the first gas path into the vapour space during inhalation, and to provide air supply from the vapour space to the mouthpiece through the first gas path. Means for exhaled gas flow transfer comprises the second valve capable of blocking the air flow in the second gas path during inhalation and allowing the exhaled gas to flow through the second gas flow path into the space for fluid. A method for lung function improval by the device and device and method application for hampered exhalation and inhalation.EFFECT: combined hampered exhalation and vapour inhalation.17 cl, 8 dwg

High-frequency oscillatory lungs fan control system // 2618086
FIELD: medicine.SUBSTANCE: high frequency oscillatory fan contains an oscillating piston control system comprising a self-centering oscillating piston configured to maintain a neutral position; mean airway pressure control system comprising a mean airway pressure controller and an exhalation valve and configured to control the exhalation valve, the oscillating piston control system and the mean airway pressure control system are closed loop control systems. The oscillating piston control system is independent on the said mean airway pressure control system. The oscillating pressure amplitude control system with feedback is adapted to facilitate control of oscillating pressure amplitude and is a closed loop control system, independent on the said oscillating piston control system and the said mean airway pressure control system. Each system is capable of independent parameter adjustment. A method for controlling a high-frequency oscillating fan is disclosed.EFFECT: simplified adjustment process and avoiding of automated change of related parameters.9 cl, 4 dwg

Patient interface device with surface engineered to provide low friction and increased comfort for user // 2617246
FIELD: medicine.SUBSTANCE: patient interface device includes an elastomeric contact portion configured to engage directly with the user's skin. The contact portion has an engineered surface comprising a plurality of predetermined non-random surface elements configured to reduce friction and improve comfort for the user. For one option, the pitch between each pair of immediately adjacent surface elements is less or equal to the predetermined maximum pitch, wherein the height of each surface element is less than or equal to the predetermined maximum height value.EFFECT: reduced mask friction on the user's skin.18 cl, 18 dwg, 1 tbl

Device with oscillatory positive pressure at exhalation // 2615280
FIELD: medicine.SUBSTANCE: group of inventions relates to medical equipment. Versions of device for respiratory therapy include at least one chamber, chamber inlet, designed to receive exhaled air in it, at least one chamber output formed for release of exhaled air from at least one chamber and exhalation circuit defined between chamber inlet and at least one chamber outlet. Limiting element is placed in exhalation circuit, wherein it moves between closed position, when exhaled air flow is limited along exhalation circuit, and open position, in which exhaled air flow is less limited along exhalation circuit. Blade in liquid connection with exhalation circuit is operatively connected with limiting element and is made with possibility of reciprocal displacement between first position and second position in response to exhaled air flow along exhalation circuit.EFFECT: group of inventions enables higher clinical effectiveness.48 cl, 74 dwg
Gas generator for therapeutic application // 2614359
FIELD: medical equipment.SUBSTANCE: group of inventions relates to medical equipment. Gas generator for therapeutic application comprises device for electrolysis for electrolysis of water and formation of gas mixture, which contains hydrogen and oxygen. Gas generator for therapeutic application also has system for gas mixing, connected to device for electrolysis, containing gas mixture. System for gas mixing is intended for mixing of gas mixture with water vapor, sprayed medicinal fluid, volatile ether oil or their combination in order to form therapeutic gas inhalation for user.EFFECT: group of inventions improves patient's relaxation in treating.14 cl, 3 dwg
ethod for increasing person's workability // 2610561
FIELD: medicine, sport.SUBSTANCE: invention relates to medicine, namely to physiotherapy and sport physiology, and can be used to increase person's workability. Influence on compensatory-adaptive reactions of their organs and systems is performed. For this purpose 30 minutes before beginning physical exercise neuropeptide for intranasal impact is introduced. After that, breathing with hyperoxic oxygen-helium mixture, containing 30-70% of oxygen is performed one time. Simultaneously 15-minute impact with pulse rectangle-shaped electric current on frontomastoid zone of head is performed. Pulse duration constitutes 0.2-0.3 ms, electric current is 1-2 mA, and pulse repetition rate is 1200-1500 Hz.EFFECT: method provides expressed and fast improvement of organism/s functional state, mental and physical workability due to the total effect of the provided impact.3 tbl
ethod for treatment of cardial failure in case of thromboembolia of pulmonary artery // 2609988
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely cardiology. First, the patient is connected to the one-level CPAP therapy device. Nasal mask or oral-nasal mask is attached and expiratory pressure level is selected to the maximum possible comfortable positive end expiratory pressure (PEEP). In case if no saturation level increase relative to the initial pressure is seen in 5-10 minutes, or expiratory pressure exceeds 10-12 mm water column, or ventilation is uncomfortable for the patient, the two-level CPAP therapy device is connected. The device is adjusted by raising the level of PEEP to the maximum possible comfort pressure while raising the pressure on inspiration Inspiratory Positive All Pressure (IPAP) and controlling the rise in oxygen saturation level in capillary blood, and raising the level of saturation by 92-98% treatment is carried out based on the patient's state of health.EFFECT: invention allows to improve treatment efficiency by reducing the pressure in pulmonary arteries, which improves tolerance to physical activity due to the opening of redundant alveoli in the lungs and increase of their perfusion.1 tbl, 2 ex
ethod of vegetative imbalance correction for men with obstructive apnea-hypopnea syndrome combined with arterial hypertension // 2609051
FIELD: medicine.SUBSTANCE: invention refers to medicine, particularly to cardiology, therapy. During sleep, brief nasal non-invasive auxiliary respiratory support with constant positive air pressure (nCPAP) is provided for at least 4 hours every night. Before and at the background of nCPAP, HRV is run to define very lo frequency (VLF) and low frequency (LF) variability of heart rate. Excessive sympathetic influence on heart is considered reduced upon decrease of VLF and LF by 4 times or more.EFFECT: fast correction of vegetative imbalance for men with combined arterial hypertension and obstructive apnea-hypopnea syndrome by elimination of excessive sympathetic influence on heart and increased saturation of arterial blood haemoglobin with oxygen.4 tbl, 1 ex

Device and system for pressure relief // 2608907
FIELD: medicine.SUBSTANCE: invention relates to medical equipment. Device for pressure relief for respiratory support system comprises casing with outlet hole arranged in valve casing and sound damper. Valve has undeformed and elastically-deformable states. In undeformed state valve blocks outlet hole and air flow passes through casing. In elastically deformed state valve in response to specified pressure air flow passes through outlet hole and casing. Valve creates sound, when valve is elastically deformed and when it passes from undeformed to deformed state. Sound damper comprises centering element for centering of sound damper in pressure relief device. Sound damper is in contact with valve when valve is elastically deformed to neutralize sound created by valve. Auxiliary respiration system comprises gas source, patient's interface configured to direct gas flow from gas source to patient, and device for pressure relief. Artificial pulmonary ventilation system by constant positive airway pressure (APCPA) with variable flow comprises drive to create flow made with possibility to direct gas flow to patient's interface, patient’s interface containing APCPA generator configured to direct gas flow from drive to patient, and device for pressure relief made with possibility to provide pressure in APCPA with variable flow not exceeding specified pressure.EFFECT: reduced noise created by deformable valve, and reduction of standard deviation of valve operation pressure are achieved.23 cl, 4 dwg

System and method for insufflation and exsufflation of patient // 2606663
FIELD: medicine.SUBSTANCE: series of inventions relates to medicine. Compressed breathing gas flow is created for delivery into individual's airway at insufflation pressure level before the time of transition. Transition time is identified based on one or more parameters of insufflation. In response to identification of transition time breathing gas flow pressure is reduced from insufflation pressure to exsufflation pressure. Value of flow during exhalation by patient is determined, where flow rate indicates flow from patient’s lungs during exsufflation. Desired level indicator of flow rate is obtained. Determined value of flow rate is compared with desired level indicator of flow rate, which corresponds to desired speed of gas flow from patient’s lungs. One or more exsufflation pressures are controlled, one or more parameters of insufflation or one or more parameters of insufflation/exsufflation transition are also controlled, based on comparison of determined value of flow rate with desired level of flow rate. Wherein value of adjustment is determined on basis of difference between determined value of flow rate and desired level of flow rate. Wherein value of pressure adjustment of exsufflation increases with increase of said difference and decreases at reduction of said difference. They implement adjusted exsufflation pressure, one or more adjusted insufflation parameters and/or one or more adjusted parameters of insufflation/exsufflation transition during subsequent breathing. Method is implemented by means of system.EFFECT: group of inventions enables to optimize insufflation and exsufflation in specific patient.15 cl, 5 dwg

Adjustable locking forehead support for a patient interface device // 2604700
FIELD: medicine.SUBSTANCE: group of inventions relates to medical equipment. Device comprises a patient sealing assembly including a cushion and a frame member, and an adjustable forehead support assembly provided at the distal end of the frame member. Assembly includes an adjustment mechanism coupled to a forehead cushion. Adjustment mechanism includes a housing, a forehead cushion support member having a base portion and an elongated post member. In the locked condition, the locking member engages the elongated post member and prevents the elongated post member from moving relative to the housing, and in the unlocked condition the locking member does not engage the elongated post member such that the elongated post member and the housing are freely linearly movable with respect to one another. Structural version of the patient interface device for transporting a gas mixture is disclosed.EFFECT: inventions provide the mask component of the device in a tight enough seal against the patient's face without discomfort.11 cl, 33 dwg

ethod and arrangement for generating a gas stream comprising nitric oxide // 2604697
FIELD: medicine.SUBSTANCE: invention relates to medical devices. Intermittent flow of oxygen containing gas is provided in a method of forming oxygen containing gas flow, with the first pulse and the second pulse of oxygen containing gas, wherein between the first pulse and the second pulse of oxygen containing gas at least one gap is provided. First pulse of inert gas is provided during the first part of the gap, which follows directly downstream of the first pulse of oxygen containing gas. Pulse of gas containing nitrogen oxide is provided, during the second part of a gap, which follows immediately downstream of the first part. Second pulse of inert gas is provided during the third part of the gap, which follows immediately downstream of the second part, and the second pulse of oxygen containing gas is provided immediately downstream of the third part so, that the first pulse of oxygen containing gas, the first pulse of inert gas, pulse of gas containing nitrogen oxide, second pulse of inert gas and the second pulse of oxygen containing gas are provided for formation of gas flow. Device for supply of gas flow is disclosed.EFFECT: invention allows to minimize formation of toxic nitrogen dioxide.10 cl, 5 dwg

Device ncpap with flow division // 2602037
FIELD: medicine.SUBSTANCE: group of inventions relates to medical equipment. Nasal continuous positive airway pressure device includes an inlet, configured for receiving a single gas jet flow and connected with a high-pressure chamber and a flow splitter configured for proportionally splitting said gas jet flow into two channels for the both nares. Flow divider is used for proportional separation of gas jet flow along curved edge transition to the first channel and the second channel. Each channel is connected to the first and the second port, respectively. Flow direction divider is further configured to supply separated single gas jet flow for each of both nares in compliance with one or more anatomy of nares and/or resistance to flow path of at least one of two nares. Flow direction divider is communicated by the fluid medium with inlet by means of the nozzle. Outlet port is communicated with the first channel and the second channel and is configured to collect excess flow intended for inhalation, and to deflect, if necessary, flow of exhalation. Separated single gas jet flow is controlled in accordance with resistance to flow path, at least into one of two nares. Method for separation of gas jet flow is disclosed.EFFECT: inventions solve a problem of improving ease of use at maintenance of continuous positive airway pressure of infants.17 cl, 3 dwg

Humidifying system // 2601852
FIELD: medical equipment.SUBSTANCE: invention relates to medical devices. Method of decreasing condensation of humidifying agent in humidifying system comprises steps which provide humidifying system containing respiratory apparatus to supply a volume of gas to patient, and humidification section to feed a humidifying agent in the volume of gas . In pulse mode in the range of pulse is supplied in volume of gas humidifying agent through humidifying section. Pulse interval starts immediately after patient's exhalation or during patient's inhalation. Volume of gas is heated closer to the discharge line of respiratory apparatus in downflow direction. In the interval of pulse absence condensed humidifying agent staying in discharge line is evaporated to reduce condensation humidifying agent present in humidifying system, interval of pulse absence starts immediately after patient's inhalation or during patient's exhalation. Evaporation stage includes passage of heated gas volume through the discharge line.EFFECT: invention simplifies the process of reducing condensation.14 cl, 4 dwg
ethod for intraoperative topical diagnosis of recurrent laryngeal nerves when performing radical surgical operations on thyroid gland // 2598639
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to endocrine surgery, and can be applied in intraoperative diagnosis of recurrent laryngeal nerves. Laryngeal mask is used as anaesthetic mean. During subfascial extraction of thyroid gland by blunt and sharp ways, simultaneous stimulation of anatomical formation, assumed as recurrent laryngeal nerve, and identification of vocal folds mobility, are conducted. Stimulation of anatomical formation is performed by application of galvanic forceps. Identification of vocal folds mobility is conducted by graphic recording on display of artificial pulmonary ventilation apparatus in mode of value controlled venting of peak inspiratory pressure to Pawinit and at the moment of Paw irritation of anatomical formation assumed as recurrent laryngeal nerve. At higher Paw unlike Pawinit more than 2 cm of water column, mobility of vocal folds is diagnosed that testifies the above anatomical formation as return laryngeal nerve.EFFECT: method simplifies intraoperative topical diagnosis of recurrent laryngeal nerves, reducing rate of treatment-induced injuries of recurrent laryngeal nerves and complications of anesthesia care, owing to use of laryngeal mask, galvanic forceps, and evaluation of difference of peak inspiratory pressure before and after irritation of anatomical formation assumed as recurrent laryngeal nerve.1 cl, 1 ex

ethod and device for forming high-speed no-containing gas flow for action on biological object // 2597131
FIELD: medical equipment.SUBSTANCE: group of inventions relates to medical equipment. Method for forming high-speed NO-containing gas flow for action on biological object comprises forming high-speed air flow by creating certain excess air pressure in a high-pressure chamber and its flowing through the nozzle which forms the flow. High-speed air flow and NO-containing gas flow is mixed in a mixing chamber, through which the high-speed air flow passes and NO-containing gas flow is supplied with monitoring of its supply. Device for forming high-speed NO-containing gas flow for action on biological object comprises a pressure sensor which is connected in series to the input of the mixing chamber and output of the device for forming high-speed NO-containing gas flow.EFFECT: technical result is forming mixed air and NO flow with monitoring the supply of the second component.2 cl, 1 dwg

Respiratory trainer // 2596886
FIELD: medicine.SUBSTANCE: group of inventions includes three versions of respiratory simulators, refers to medical equipment, to drug-free means of obtaining general therapeutic exposure and increase of human physical capacities through the respiratory system, in particular to devices for respiratory hypoxic-hypercapnic mixtures of different compositions with variable resistance inhalation/exhalation. According to first version, respiratory trainer comprises first chamber connected with connection of training device to user's airways, second chamber communicated with first chamber, third chamber communicated with second chamber, respired gas composition control means, control means of inhalation/exhalation resistance, installed in communication channel of first chamber to second chamber. Second chamber is communicated with atmosphere, third chamber is made elastic, respired gas composition control means are made as adjustable throttle device installed in communication channel of second chamber with third chamber, and adjustable throttle device installed in communication channel of second chamber with atmosphere. Control means of inhalation/exhalation resistance are made with possibility of separate and independent control of inhalation resistance and exhalation resistance.EFFECT: respiratory trainer adjustment (changing) composition of hypoxic-hypercapnic respiratory mixture in wide range using simple equipment, using special breathing mixtures, as well as separate and independent control of resistance (obstacle) to inhalation and exhalation, which broadens possibility of selecting modes of use of training device and possibility of its health-improving impact on organism.32 cl, 43 dwg

Active valve for ventilators // 2595479
FIELD: medical equipment.SUBSTANCE: group of inventions relates to medical equipment. Valve for controlling pressure in a ventilation system comprises an electromagnet, including coil and magnet; rod connected with electromagnet; diaphragm, connected with rod, and a controller to receive electric signal from pressure sensor, configured to feed input signal to valve based on electric signal, wherein electromagnet is configured to apply force to diaphragm via rod based on input signal. Controller is configured to change direction of current in coil to lift diaphragm of valve to provide for air release into environment via hole in connection with patient's circuit if pressure in patient's circuit exceeds threshold of positive pressure and lifting diaphragm of valve to feed air from outside through hole in connection when pressure falls in circuit of patient below threshold of negative pressure. Disclosed is a pulmonary ventilation system using valve.EFFECT: invention enables to change threshold pressure during ventilation.10 cl, 3 dwg

System and method for treatment of hypoventilation in obesity // 2594808
FIELD: medical equipment.SUBSTANCE: group of inventions relates to medical equipment. System for gas delivery of under pressure into anatomical airways comprises a pressure generator, sensors made to generate output signals carrying information related to respiratory force of subject, processors configured to execute computer program modules. Respiratory volume determination module determines target average respiratory volume. Control module is configured to control pressure generator so that average respiratory volume is maintained during respiration for the individual. Inspiratory pressure module is configured to determine pressure level after inhalation, which will maintain target average respiratory volume. Module for determining frequency is configured to dynamically determining current respiratory rate subject. Expiratory pressure module is configured to determine the expiratory pressure level, which will maintain target average respiratory volume. Control module is configured to control pressure generator so that breath is adjusted to maintain it for therapeutic breathing frequency. Invention discloses a method for determining levels of pressure gas flow and version of the system for delivery of gas flow.EFFECT: inventions allow to treat hypoventilation syndrome in obesity.15 cl, 4 dwg
ethod of general controlled human body hyperthermia // 2594430
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to anaesthesiology and resuscitation, and can be used for general controlled hyperthermia of human organism. This is ensured by planned infusion preparation. Before immersing the patient in hot water 1 mg/ml of Dalargin is administered intravenously. Then patient's body is totally heated up by immersion, except the head, in hot water with temperature of 42-47 °C at the rate of body heating equal to 0.5-1.5 °C for 5 minutes with saturation within normal limits up to temperature increase in esophagus till 42.5-44 °C. Temperature is measured in the middle one-third part of oesophagus. Additionally temperature is measured on the eardrum. Besides, anaesthesiology protection is provided by introducing relaxing agents, anesthetics and hypnotic drugs. Hyperthermia is carried out with monitoring of pulse frequency, heart, blood pressure values, saturation. BIS-monitoring is carried out. According to BIS-monitoring with simultaneous reduction of heating rate a biological critical point is determined. During hyperthermia Dalargin is introduced in the above dose at each degree starting from 40 °C being measured in esophagus, as well as at biological critical point. For 5-20 minutes effective warming is maintained not extending beyond the biological critical point. Pathogenetically substantiated drugs are administered depending on the available pathology. Then the patient is removed from the bath and normal temperature is restored.EFFECT: method provides higher clinical effectiveness due to selection of reliable criteria reaching maximum heating, establishing exposure time and peak hyperthermia, as well as a result of administration of drug preventing possible development of thermal shock.1 cl, 1 ex

Humidifying system for humidification of gas delivered to patient // 2594241
FIELD: medicine. SUBSTANCE: humidifying system for humidifying gas delivered to a patient comprises a source of liquid and a humidifying unit, located in patient's circuit, which provides gas to patient. Humidification unit comprises: a liquid chamber that receives liquid from liquid source wherein liquid chamber includes a concave shaped bottom portion, a nebuliser that nebulises liquid from liquid chamber, wherein nebuliser is located at bottom portion ofliquid chamber so that liquid introduced into liquid chamber is funneled towards nebuliser; an aerosol chamber that receives aerosolised particles from nebuliser; a heat source located in aerosol chamber that converts aerosolised particles into a vapour that humidifies gas in patient circuit, and a hydrophobic membrane that separates aerosol chamber from patient circuit, and wherein hydrophobic membrane prevents liquid from entering the patient circuit from aerosol chamber but permits vapour to enter patient circuit from aerosol chamber. Nebuliser comprises an aperture plate with holes, aperture plate being coupled to a vibrational element, wherein vibration of vibrational element causes aperture plate to vibrate, which causes liquid to move through aperture plate holes for nebulising fluid into aerosolised particles. Method includes steps of operating said system. EFFECT: using given group of inventions will allow to reduce power consumption, elimination of condensation or water in tubes humidifier or circuits of patient. 6 cl, 4 dwg